Roots Analysis is pleased to announce the publication of its recent study,titled, “Large Volume Wearable Injectors Market (5th Edition), 2020-2030:Focus on Bolus, Basal and Continuous Delivery Devices.”
The report featuresan extensive study of the current market landscape, offering an informedopinion on the likely future evolution of these self-injection devices over thenext decade. It features an in-depth analysis, highlighting the capabilities ofvarious stakeholders engaged in this domain. In addition to other elements, thestudy includes:
§ A detailed review ofthe overall landscape of large volume wearable injectors available for deliveryof insulin and non-insulin drugs, in addition to the under development /available drug device combinations
§ An insightfulcompetitiveness analysis of large volume wearable injectors based on variousrelevant parameters, such as supplier power and product specifications
§ Elaborate profiles ofthe prominent companies that develop large volume wearable injectors.
§ An analysis of thepartnerships that have been established in the period between 2015 and 2020.
§ A detailed analysison acquisition targets.
§ An in-depth analysisof the various patents that have been submitted / filed related to large volumewearable injectors over the last three decades.
§ A list of marketeddrugs / therapies and pipeline candidates that are likely to be developed incombination with large volume wearable injectors in the near future
§ A social mediaanalysis depicting prevalent and emerging trends, and the popularity of large volumewearable injectors on Twitter
§ A detailed analysisof completed, ongoing and planned clinical trials
§ A case study on therole of contract manufacturing organizations in the overall manufacturingprocess / supply chain
§ An elaboratediscussion on the various guidelines established by major regulatory bodies formedical device approval, in general.
§ A detailed marketforecast, featuring analysis of the financial opportunity within the largevolume wearable injectors market (fordelivery of non-insulin and insulin drugs) across the following segments:
- Type of Device
§ Patch Pump /Injectors
§ Infusion Pump /Injectors
- Product Usability
§ Disposable
§ Re-usable
- Therapeutics Area (for non-insulin drugs)
§ NeurologicalDisorders
§ CardiovascularDisorders
§ Oncological Disorders
§ Infectious Disorders
- Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
Key companies covered in the report:
§ Becton Dickinson
§ Bespak (subsidiary of Consort Medical)
§ CeQur
§ Debiotech
§ Eli Lilly
§ Enable Injections
§ Insulet
§ Medtronic
§ PharmaSens
§ Roche
§ SOOIL Development
§ Sonceboz
§ Sensile Medical (acquired by Gerresheimer)
§ SteadyMed Therapeutics (acquired by United Therapeutics)
§ Tandem Diabetes Care
§ Weibel CDS (acquired by SHL Medical)
§ West Pharmaceutical Services
For more information,please click on the following link:
Other recentofferings:
1. Microneedles andNeedle-Free Injection Systems / JetInjectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030[COVID-19 Series]
2. Global Autoinjectors Market (3rd Edition), 2020-2030
3. Prefilled SyringesMarket (5th Edition), 2020-2030
About Roots Analysis
Roots Analysis is oneof the fastest growing market research companies, sharing fresh and independentperspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots AnalysisPrivate Limited
Gaurav Chaudhary
+1 (415) 800 3415
